Sander Kersten

33.4k total citations · 11 hit papers
228 papers, 25.3k citations indexed

About

Sander Kersten is a scholar working on Molecular Biology, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Sander Kersten has authored 228 papers receiving a total of 25.3k indexed citations (citations by other indexed papers that have themselves been cited), including 114 papers in Molecular Biology, 88 papers in Physiology and 76 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Sander Kersten's work include Adipose Tissue and Metabolism (76 papers), Lipid metabolism and disorders (74 papers) and Peroxisome Proliferator-Activated Receptors (68 papers). Sander Kersten is often cited by papers focused on Adipose Tissue and Metabolism (76 papers), Lipid metabolism and disorders (74 papers) and Peroxisome Proliferator-Activated Receptors (68 papers). Sander Kersten collaborates with scholars based in Netherlands, United States and Switzerland. Sander Kersten's co-authors include Michael Müller, Walter Wahli, Béatrice Desvergne, Stéphane Mandard, Rinke Stienstra, M. M�ller, Frank J. Gonzalez, Maryam Rakhshandehroo, Nguan Soon Tan and Patrick Schrauwen and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Sander Kersten

225 papers receiving 24.9k citations

Hit Papers

Roles of PPARs in health ... 1999 2026 2008 2017 2000 1999 2004 2011 2010 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Roles of PPARs in health and disease
    2000 1.6k citations Sander Kersten, Béatrice Desvergne et al. profile →
  2. Peroxisome proliferator–activated receptor α mediates the adaptive response to fasting
    1999 1.4k citations Sander Kersten, Béatrice Desvergne et al. Journal of Clinical Investigation profile →
  3. Peroxisome proliferator-activated receptor a target genes
    2004 1.1k citations Stéphane Mandard, Sander Kersten et al. profile →
  4. Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans
    2011 1.0k citations Joris Hoeks, Sander Kersten et al. profile →
  5. Peroxisome Proliferator-Activated Receptor Alpha Target Genes
    2010 825 citations Maryam Rakhshandehroo, Michael Müller et al. profile →
  6. The Inflammasome-Mediated Caspase-1 Activation Controls Adipocyte Differentiation and Insulin Sensitivity
    2010 538 citations Rinke Stienstra, Sander Kersten et al. profile →
  7. Mechanisms of nutritional and hormonal regulation of lipogenesis
    2001 529 citations Sander Kersten profile →
  8. Integrated physiology and systems biology of PPARα
    2014 468 citations Sander Kersten Molecular Metabolism profile →
  9. Short-term cold acclimation improves insulin sensitivity in patients with type 2 diabetes mellitus
    2015 449 citations Joris Hoeks, Gert Schaart et al. profile →
  10. Physiological regulation of lipoprotein lipase
    2014 410 citations Sander Kersten profile →
  11. Systemic PFOS and PFOA exposure and disturbed lipid homeostasis in humans: what do we know and what not?
    2021 141 citations Styliani Fragki, Hubert Dirven et al. Critical Reviews in Toxicology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Sander Kersten 11.6k 8.5k 6.1k 5.0k 3.9k 228 25.3k
Antonio Vidal‐Puig 12.2k 1.1× 12.8k 1.5× 7.4k 1.2× 2.5k 0.5× 2.5k 0.7× 313 26.0k
Aimin Xu 15.0k 1.3× 10.3k 1.2× 12.4k 2.0× 5.0k 1.0× 3.8k 1.0× 524 33.4k
Jason K. Kim 13.5k 1.2× 9.4k 1.1× 6.6k 1.1× 2.1k 0.4× 3.7k 1.0× 197 25.4k
Clay F. Semenkovich 13.0k 1.1× 8.7k 1.0× 4.0k 0.7× 2.0k 0.4× 3.3k 0.9× 189 22.3k
Hubert Vidal 11.4k 1.0× 10.5k 1.2× 6.2k 1.0× 1.9k 0.4× 3.0k 0.8× 346 25.3k
Ira J. Goldberg 9.1k 0.8× 5.1k 0.6× 3.9k 0.6× 7.9k 1.6× 7.5k 1.9× 336 25.9k
Evan D. Rosen 13.1k 1.1× 11.5k 1.4× 7.4k 1.2× 2.0k 0.4× 1.7k 0.4× 106 25.1k
Rudolf Zechner 10.3k 0.9× 11.2k 1.3× 4.8k 0.8× 3.5k 0.7× 3.0k 0.8× 248 26.0k
Brian N. Finck 8.8k 0.8× 5.7k 0.7× 4.0k 0.7× 2.6k 0.5× 1.9k 0.5× 191 17.9k
Nada A. Abumrad 9.5k 0.8× 5.4k 0.6× 3.1k 0.5× 1.9k 0.4× 2.4k 0.6× 179 18.4k

Countries citing papers authored by Sander Kersten

Since Specialization
Citations

This map shows the geographic impact of Sander Kersten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sander Kersten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sander Kersten more than expected).

Fields of papers citing papers by Sander Kersten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sander Kersten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sander Kersten. The network helps show where Sander Kersten may publish in the future.

Co-authorship network of co-authors of Sander Kersten

This figure shows the co-authorship network connecting the top 25 collaborators of Sander Kersten. A scholar is included among the top collaborators of Sander Kersten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sander Kersten. Sander Kersten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nordestgaard, Ask Tybjærg, Anne Tybjærg‐Hansen, Hank Mansbach, et al.. (2025). Target Populations for Novel Triglyceride-Lowering Therapies. Journal of the American College of Cardiology. 85(19). 1876–1897. 11 indexed citations
2.
Henneman, Peter, et al.. (2024). Drug-target Mendelian randomization analysis supports lowering plasma ANGPTL3, ANGPTL4, and APOC3 levels as strategies for reducing cardiovascular disease risk. European Heart Journal Open. 4(3). oeae035–oeae035. 17 indexed citations
3.
Vrieling, Frank, et al.. (2024). CENCAT enables immunometabolic profiling by measuring protein synthesis via bioorthogonal noncanonical amino acid tagging. Cell Reports Methods. 4(10). 100883–100883. 4 indexed citations
4.
Deng, Lei, Frank Vrieling, Guido Hooiveld, et al.. (2023). Milk fat globule membrane modulates inflammatory pathways in human monocytes: A crossover human intervention study. Clinical Nutrition. 43(1). 232–245. 1 indexed citations
5.
Gemmink, Anne, Marlies de Ligt, Esther Kornips, et al.. (2022). Effects of SGLT2 inhibitor dapagliflozin in patients with type 2 diabetes on skeletal muscle cellular metabolism. Molecular Metabolism. 66. 101620–101620. 28 indexed citations
6.
Dierendonck, Xanthe A.M.H. van, Frank Vrieling, Lei Deng, et al.. (2022). Triglyceride breakdown from lipid droplets regulates the inflammatory response in macrophages. Proceedings of the National Academy of Sciences. 119(12). e2114739119–e2114739119. 97 indexed citations
7.
Fragki, Styliani, Hubert Dirven, Tony Fletcher, et al.. (2021). Systemic PFOS and PFOA exposure and disturbed lipid homeostasis in humans: what do we know and what not?. Critical Reviews in Toxicology. 51(2). 141–164. 141 indexed citations breakdown →
8.
Remie, Carlijn M. E., Kay H. M. Roumans, Emmani B. M. Nascimento, et al.. (2021). Metabolic responses to mild cold acclimation in type 2 diabetes patients. Nature Communications. 12(1). 1516–1516. 20 indexed citations
9.
Deng, Lei, et al.. (2021). RNA sequencing reveals niche gene expression effects of beta-hydroxybutyrate in primary myotubes. Life Science Alliance. 4(10). e202101037–e202101037. 6 indexed citations
10.
Zhou, Zhangsen, Mauricio Torres, Haibo Sha, et al.. (2020). Endoplasmic reticulum–associated degradation regulates mitochondrial dynamics in brown adipocytes. Science. 368(6486). 54–60. 147 indexed citations
11.
Oteng, Antwi‐Boasiako, Anke Loregger, Michel van Weeghel, Noam Zelcer, & Sander Kersten. (2019). Industrial Trans Fatty Acids Stimulate SREBP2‐Mediated Cholesterogenesis and Promote Non‐Alcoholic Fatty Liver Disease. Molecular Nutrition & Food Research. 63(19). e1900385–e1900385. 36 indexed citations
12.
Bhattacharya, Asmita, Shengyi Sun, Ming Liu, et al.. (2018). Hepatic Sel1L‐Hrd1 ER‐associated degradation (ERAD) manages FGF21 levels and systemic metabolism via CREBH. The EMBO Journal. 37(22). 65 indexed citations
13.
Janssen, Aafke W. F., Tom Houben, Saeed Katiraei, et al.. (2017). Modulation of the gut microbiota impacts nonalcoholic fatty liver disease: a potential role for bile acids. Journal of Lipid Research. 58(7). 1399–1416. 97 indexed citations
14.
Janssen, Aafke W. F. & Sander Kersten. (2015). The role of the gut microbiota in metabolic health. The FASEB Journal. 29(8). 3111–3123. 145 indexed citations
15.
Sun, Shengyi, Guojun Shi, Xuemei Han, et al.. (2014). Sel1L is indispensable for mammalian endoplasmic reticulum-associated degradation, endoplasmic reticulum homeostasis, and survival. Proceedings of the National Academy of Sciences. 111(5). E582–91. 160 indexed citations
16.
Sun, Shengyi, Yewei Ji, Sander Kersten, & Ling Qi. (2012). Mechanisms of Inflammatory Responses in Obese Adipose Tissue. Annual Review of Nutrition. 32(1). 261–286. 236 indexed citations
17.
Schipper, Henk S., Maryam Rakhshandehroo, Stan F.J. van de Graaf, et al.. (2012). Natural killer T cells in adipose tissue prevent insulin resistance. Journal of Clinical Investigation. 122(9). 3343–3354. 164 indexed citations
18.
Georgiadi, Anastasia, Laeticia Lichtenstein, Tatjana Degenhardt, et al.. (2010). Induction of Cardiac Angptl4 by Dietary Fatty Acids Is Mediated by Peroxisome Proliferator-Activated Receptor β/δ and Protects Against Fatty Acid–Induced Oxidative Stress. Circulation Research. 106(11). 1712–1721. 125 indexed citations
19.
Sanderson, Linda M., Tatjana Degenhardt, Arjen Koppen, et al.. (2009). Peroxisome Proliferator-Activated Receptor β/δ (PPARβ/δ) but Not PPARα Serves as a Plasma Free Fatty Acid Sensor in Liver. Molecular and Cellular Biology. 29(23). 6257–6267. 117 indexed citations
20.
Kersten, Sander. (2001). Mechanisms of nutritional and hormonal regulation of lipogenesis. The EMBO Journal. 2. 282–286. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antonio Vidal‐Puig Breakdown of academic impact, for papers by Aimin Xu Breakdown of academic impact, for papers by Jason K. Kim Breakdown of academic impact, for papers by Clay F. Semenkovich Breakdown of academic impact, for papers by Hubert Vidal Breakdown of academic impact, for papers by Ira J. Goldberg Breakdown of academic impact, for papers by Evan D. Rosen Breakdown of academic impact, for papers by Rudolf Zechner Breakdown of academic impact, for papers by Brian N. Finck Breakdown of academic impact, for papers by Nada A. Abumrad
Rankless by CCL
2026